{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T10:40:22Z","timestamp":1767177622950,"version":"build-2238731810"},"update-to":[{"DOI":"10.1371\/journal.pntd.0011441","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000}}],"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T00:00:00Z","timestamp":1688688000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014445","name":"Fred Hollows Foundation","doi-asserted-by":"publisher","award":["1954-0"],"award-info":[{"award-number":["1954-0"]}],"id":[{"id":"10.13039\/100014445","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017151","name":"Queen Elizabeth Diamond Jubilee Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017151","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004436","name":"Commonwealth Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>\n                    Baseline mapping in the two major population centers of Kiribati showed that trachoma was a public health problem in need of programmatic interventions. After conducting two annual rounds of antibiotic mass drug administration (MDA), Kiribati undertook trachoma impact surveys in 2019, using standardized two-stage cluster surveys in the evaluation units of Kiritimati Island and Tarawa. In Kiritimati, 516 households were visited and in Tarawa, 772 households were visited. Nearly all households had a drinking water source and access to an improved latrine. The prevalence of trachomatous trichiasis remained above the elimination threshold (0.2% in \u226515-year-olds) and was virtually unchanged from baseline. The prevalence of trachomatous inflammation\u2014follicular (TF) in 1\u20139-year-olds decreased by approximately 40% from baseline in both evaluation units but remained above the 5% TF prevalence threshold for stopping MDA. TF prevalence at impact survey was 11.5% in Kiritimati and 17.9% in Tarawa. Infection prevalence in 1\u20139-year-olds by PCR was 0.96% in Kiritimati and 3.3% in Tarawa. Using a multiplex bead assay to measure antibodies to the\n                    <jats:italic>C<\/jats:italic>\n                    .\n                    <jats:italic>trachomatis<\/jats:italic>\n                    antigen Pgp3, seroprevalence in 1\u20139-year-olds was 30.2% in Kiritimati and 31.4% in Tarawa. The seroconversion rate, in seroconversion events\/100 children\/year, was 9.0 in Kiritimati and 9.2 in Tarawa. Seroprevalence and seroconversion rates were both assessed by four different assays, with strong agreement between tests. These results show that, despite decreases in indicators associated with infection at impact survey, trachoma remains a public health problem in Kiribati, and provide additional information about changes in serological indicators after MDA.\n                  <\/jats:p>","DOI":"10.1371\/journal.pntd.0011441","type":"journal-article","created":{"date-parts":[[2023,7,7]],"date-time":"2023-07-07T13:44:09Z","timestamp":1688737449000},"page":"e0011441","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Changes in trachoma indicators in Kiribati with two rounds of azithromycin mass drug administration, measured in serial population-based surveys"],"prefix":"10.1371","volume":"17","author":[{"given":"E. Brook","family":"Goodhew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raebwebwe","family":"Taoaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma M.","family":"Harding-Esch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Gwyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Bakhtiari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Butcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anasaini","family":"Cama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah Anne J.","family":"Guagliardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caleb D.","family":"Mpyet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kab","family":"Tun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karana","family":"Wickens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony W.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9417-5562","authenticated-orcid":true,"given":"Diana L.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabebe","family":"Tekeraoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,7,7]]},"reference":[{"key":"pntd.0011441.ref001","article-title":"WHO Alliance for the Global Elimination of Trachoma: progress report on elimination of trachoma, 2021","author":"World Health Organization","year":"2022","journal-title":"Weekly Epidemiological Record"},{"issue":"4","key":"pntd.0011441.ref002","first-page":"477","article-title":"A simple system for the assessment of trachoma and its complications","volume":"65","author":"B Thylefors","year":"1987","journal-title":"Bull World Health Organ"},{"issue":"30","key":"pntd.0011441.ref003","first-page":"349","article-title":"WHO Alliance for the Global Elimination of Trachoma by 2020","volume":"95","author":"World Health Organization","year":"2020","journal-title":"progress report, 2019. Weekly Epidemiological Record"},{"key":"pntd.0011441.ref004","volume-title":"Report of the 3rd Global Scientific Meeting on Trachoma","author":"World Health Organization","year":"2010"},{"issue":"10","key":"pntd.0011441.ref005","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2471\/BLT.19.248708","article-title":"The simplified trachoma grading system, amended","volume":"98","author":"AW Solomon","year":"2020","journal-title":"Bull World Health Organ"},{"issue":"1","key":"pntd.0011441.ref006","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12879-019-3935-1","article-title":"Understanding the spatial distribution of trichiasis and its association with trachomatous inflammation-follicular","volume":"19","author":"RM Flueckiger","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"4","key":"pntd.0011441.ref007","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jinf.2020.01.015","article-title":"Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma","volume":"80","author":"R Butcher","year":"2020","journal-title":"J Infect"},{"issue":"9","key":"pntd.0011441.ref008","doi-asserted-by":"crossref","first-page":"e0005863","DOI":"10.1371\/journal.pntd.0005863","article-title":"Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati","volume":"11","author":"A Cama","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0011441.ref009","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4269\/ajtmh.20-0777","article-title":"Population-Based Prevalence of Chlamydia trachomatis Infection and Antibodies in Four Districts with Varying Levels of Trachoma Endemicity in Amhara, Ethiopia","volume":"104","author":"SD Nash","year":"2021","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"pntd.0011441.ref010","doi-asserted-by":"crossref","first-page":"e462","DOI":"10.1371\/journal.pntd.0000462","article-title":"The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control","volume":"3","author":"M Gambhir","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"pntd.0011441.ref011","doi-asserted-by":"crossref","first-page":"e0008316","DOI":"10.1371\/journal.pntd.0008316","article-title":"The use of serology for trachoma surveillance: Current status and priorities for future investigation","volume":"14","author":"DL Martin","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"pntd.0011441.ref012","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3109\/09286586.2015.1037401","article-title":"The Global Trachoma Mapping Project: Methodology of a 34-Country Population-Based Study","volume":"22","author":"AW Solomon","year":"2015","journal-title":"Ophthalmic Epidemiol"},{"issue":"5\u20136","key":"pntd.0011441.ref013","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/09286586.2018.1500616","article-title":"A diagnostic instrument to help field graders evaluate active trachoma","volume":"25","author":"AW Solomon","year":"2018","journal-title":"Ophthalmic Epidemiol"},{"issue":"11","key":"pntd.0011441.ref014","doi-asserted-by":"crossref","first-page":"e1873","DOI":"10.1371\/journal.pntd.0001873","article-title":"CT694 and pgp3 as serological tools for monitoring trachoma programs","volume":"6","author":"EB Goodhew","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"pntd.0011441.ref015","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.4269\/ajtmh.21-0541","article-title":"The Performance of Immunoassays to Measure Antibodies to the Chlamydia trachomatis Antigen Pgp3 in Different Epidemiological Settings for Trachoma","volume":"105","author":"S Gwyn","year":"2021","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pntd.0011441.ref016","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.1038\/s41598-021-86639-8","article-title":"Comparison of platforms for testing antibodies to Chlamydia trachomatis antigens in the Democratic Republic of the Congo and Togo","volume":"11","author":"S Gwyn","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"pntd.0011441.ref017","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1038\/s41598-018-22708-9","article-title":"Latent class modeling to compare testing platforms for detection of antibodies against the Chlamydia trachomatis antigen Pgp3","volume":"8","author":"RE Wiegand","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"pntd.0011441.ref018","doi-asserted-by":"crossref","first-page":"e0005230","DOI":"10.1371\/journal.pntd.0005230","article-title":"Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies","volume":"11","author":"SJ Migchelsen","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"pntd.0011441.ref019","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1128\/JCM.00519-13","article-title":"Comparison of the Abbott m2000 RealTime CT assay and the Cepheid GeneXpert CT\/NG assay to the Roche Amplicor CT assay for detection of Chlamydia trachomatis in ocular samples from Tanzania","volume":"51","author":"L Dize","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"12","key":"pntd.0011441.ref020","first-page":"575","article-title":"Serology","volume":"23","author":"P Corran","year":"2007","journal-title":"a robust indicator of malaria transmission intensity? Trends Parasitol"},{"issue":"14","key":"pntd.0011441.ref021","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1073\/pnas.0408725102","article-title":"Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure","volume":"102","author":"CJ Drakeley","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pntd.0011441.ref022","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1038\/s41467-018-07852-0","article-title":"The utility of serology for elimination surveillance of trachoma","volume":"9","author":"A Pinsent","year":"2018","journal-title":"Nat Commun"},{"key":"pntd.0011441.ref023","volume-title":"A Guide for Program Managers","author":"ZM Solomon A","year":"2006"},{"issue":"1","key":"pntd.0011441.ref024","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4269\/ajtmh.17-0102","article-title":"Prevalence of Chlamydia trachomatis-Specific Antibodies before and after Mass Drug Administration for Trachoma in Community-Wide Surveys of Four Communities in Nepal","volume":"98","author":"SE Gwyn","year":"2018","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"pntd.0011441.ref025","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1038\/s41598-018-21127-0","article-title":"Longitudinal change in the serology of antibodies to Chlamydia trachomatis pgp3 in children residing in a trachoma area","volume":"8","author":"SK West","year":"2018","journal-title":"Sci Rep"},{"key":"pntd.0011441.ref026","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/1471-2334-14-216","article-title":"Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration","volume":"14","author":"EB Goodhew","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"19","key":"pntd.0011441.ref027","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1056\/NEJMoa040979","article-title":"Mass treatment with single-dose azithromycin for trachoma","volume":"351","author":"AW Solomon","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"pntd.0011441.ref028","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1167\/iovs.06-0625","article-title":"Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village","volume":"48","author":"SK West","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"pntd.0011441.ref029","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1371\/journal.pntd.0000376","article-title":"Reduction and return of infectious trachoma in severely affected communities in Ethiopia","volume":"3","author":"T Lakew","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0011441.ref030","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1186\/s13071-019-3743-x","article-title":"Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal","volume":"12","author":"EM Harding-Esch","year":"2019","journal-title":"Parasit Vectors"},{"issue":"6","key":"pntd.0011441.ref031","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.4269\/ajtmh.17-0292","article-title":"Comparison of Platforms for Testing Antibody Responses against the Chlamydia trachomatis Antigen Pgp3","volume":"97","author":"S Gwyn","year":"2017","journal-title":"Am J Trop Med Hyg"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0011441","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0011441","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T16:42:49Z","timestamp":1689784969000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0011441"}},"subtitle":[],"editor":[{"given":"Jeremiah M.","family":"Ngondi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,7,7]]},"references-count":31,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0011441","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,7]]}}}